Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
615.65615.07619.70614.21
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
551.24548.70548.70530.09
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
947.08946.19946.19917.62
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
464.75463.99464.64453.17
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
1,094.451,093.531,102.341,089.23
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
536.07535.49537.10532.16
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
894.96895.33896.45886.07
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
316.30317.30317.88312.06
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
1,123.351,118.991,118.991,092.58
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
862.09841.63841.63810.46
Q1 2026 earnings • released • EPS miss -21.64% • Revenue miss -74.68%
See results
RGNX:NASDAQ
Regenxbio Inc
$5.72
-8.41%
(-0.53) 1D
$5.79
+1.23% (+0.070)
After hours
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGNX...
Open
$6.25
High
$6.48
Low
$5.71
Mkt. cap
295.01M
Avg. vol.
1.06M
Volume
4.35M
52-wk high
$16.19
52-wk low
$5.71
EPS
-$3.76
Beta
1.12
Shares outstanding
51.62M
No. of employees
371
News stories
From sources across the web
About Regenxbio Inc
CEO-
Employees371
Founded2008
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Last report
May 14, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$1.72 / -$1.41
-21.64%miss
Revenue / Est. (USD)
6.39M / 25.25M
-74.68%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
21.36M
29.73M
30.34M
6.39M
Cost of goods sold
64.71M
61.83M
65.54M
68.41M
Cost of revenue
64.71M
61.83M
65.54M
68.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.88M
20.25M
22.38M
21.31M
Operating expense
19.93M
20.32M
22.43M
21.34M
Total operating expenses
84.64M
82.14M
87.97M
89.76M
Operating income
-63.28M
-52.41M
-57.64M
-83.36M
Other non operating income
-
-
-
-
EBT including unusual items
-70.87M
-61.94M
-67.15M
-90.05M
EBT excluding unusual items
-70.87M
-61.94M
-67.15M
-90.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
45.00K
65.00K
54.00K
36.00K
Net income
-70.87M
-61.94M
-67.15M
-90.05M
Net profit margin
-331.81%
-208.32%
-221.34%
-1,408.59%
Earnings per share
-1.38
-1.20
-1.30
-1.72
Interest and investment income
3.40M
3.64M
2.76M
2.02M
Interest expense
-10.99M
-13.17M
-12.28M
-8.71M
Net interest expenses
-7.59M
-9.53M
-9.51M
-6.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
-59.37M
-48.52M
-53.77M
-79.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more